Warning: Invalid argument supplied for foreach() in /home/globaldi/public_html/modules/mod_banners/tmpl/default.php on line 9
NKF-FDA workshop reviews endpoints for studies of chronic kidney disease. |
|
|
NKF: After extensive analysis of data from observational cohorts and interventional trials, the workshop planning committee and attendees recommended a 30 or 40% decline in glomerular filtration rate (GFR) as new surrogate endpoints for some clinical trials in chronic kidney disease used for regulatory approval.
|